SMAD4 transcription is upregulated by p53

被引:0
|
作者
Dandaleh, Fadi S. [1 ]
Calva-Cerqueira, Daniel [1 ]
Woodfield, George [1 ]
Weigel, Ronald J. [1 ]
Howe, James R. [1 ]
机构
[1] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:S119 / S119
页数:1
相关论文
共 50 条
  • [1] Smad4 and p53 synergize in suppressing autochthonous intestinal cancer
    Park, Jun Won
    Seo, Min-Jung
    Cho, Kye Soo
    Kook, Myeong-Cherl
    Jeong, Jong Min
    Roh, Seul-Gi
    Cho, Soo Young
    Cheon, Jae Hee
    Kim, Hark Kyun
    CANCER MEDICINE, 2022, 11 (09): : 1925 - 1936
  • [2] Cancerization of Bile Ducts in Hilar Cholangiocarcinomas: Immunophenotyping Using P53 and SMAD4
    Zhang, Yang
    Alruwaii, Zainab
    Larman, Tatianna
    Miller, James
    Anders, Robert
    Oshima, Kiyoko
    MODERN PATHOLOGY, 2019, 32
  • [3] Cancerization of Bile Ducts in Hilar Cholangiocarcinomas: Immunophenotyping Using P53 and SMAD4
    Zhang, Yang
    Alruwaii, Zainab
    Larman, Tatianna
    Miller, James
    Anders, Robert
    Oshima, Kiyoko
    LABORATORY INVESTIGATION, 2019, 99
  • [4] Impact of Smad4 and p53 mutations on the prognosis of patients with pancreatic ductal adenocarcinoma undergoing chemotherapy
    Kamata, Ken
    Takenaka, Mamoru
    Nishida, Naoshi
    Hara, Akane
    Otsuka, Yasuo
    Tanaka, Hidekazu
    Omoto, Shunsuke
    Minaga, Kosuke
    Yamao, Kentaro
    Chiba, Yasutaka
    Sakai, Kazuko
    Nishio, Kazuto
    Watanabe, Tomohiro
    Kudo, Masatoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (11) : 1511 - 1519
  • [5] Impact of Smad4 and p53 mutations on the prognosis of patients with pancreatic ductal adenocarcinoma undergoing chemotherapy
    Ken Kamata
    Mamoru Takenaka
    Naoshi Nishida
    Akane Hara
    Yasuo Otsuka
    Hidekazu Tanaka
    Shunsuke Omoto
    Kosuke Minaga
    Kentaro Yamao
    Yasutaka Chiba
    Kazuko Sakai
    Kazuto Nishio
    Tomohiro Watanabe
    Masatoshi Kudo
    International Journal of Clinical Oncology, 2023, 28 : 1511 - 1519
  • [6] Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study
    Chunan Bian
    Zhongyou Li
    Youtao Xu
    Jie Wang
    Lin Xu
    Hongbing Shen
    World Journal of Surgical Oncology, 13
  • [7] Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study
    Bian, Chunan
    Li, Zhongyou
    Xu, Youtao
    Wang, Jie
    Xu, Lin
    Shen, Hongbing
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [8] The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC
    P W Voorneveld
    L L Kodach
    R J Jacobs
    C J M van Noesel
    M P Peppelenbosch
    K S Korkmaz
    I Molendijk
    E Dekker
    H Morreau
    G W van Pelt
    R A E M Tollenaar
    W Mesker
    L J A C Hawinkels
    M Paauwe
    H W Verspaget
    D T Geraets
    D W Hommes
    G J A Offerhaus
    G R van den Brink
    P ten Dijke
    J C H Hardwick
    British Journal of Cancer, 2015, 112 : 122 - 130
  • [9] The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC
    Voorneveld, P. W.
    Kodach, L. L.
    Jacobs, R. J.
    van Noesel, C. J. M.
    Peppelenbosch, M. P.
    Korkmaz, K. S.
    Molendijk, I.
    Dekker, E.
    Morreau, H.
    van Pelt, G. W.
    Tollenaar, R. A. E. M.
    Mesker, W.
    Hawinkels, L. J. A. C.
    Paauwe, M.
    Verspaget, H. W.
    Geraets, D. T.
    Hommes, D. W.
    Offerhaus, G. J. A.
    van den Brink, G. R.
    ten Dijke, P.
    Hardwick, J. C. H.
    BRITISH JOURNAL OF CANCER, 2015, 112 (01) : 122 - 130
  • [10] Immunohistochemical Staining for p53, Smad4 and ARID1A Improves the Evaluation of Bile Duct Biopsies
    Wilhelm, Alyeesha
    Smith, Katelyn
    Singhi, Aatur
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1866 - S1866